Picture of Takara Bio logo

4974 Takara Bio Cashflow Statement

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapFalling Star

Annual cashflow statement for Takara Bio, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:YuhoYuhoYuhoYuhoYuho
Standards:
JAS
JAS
JAS
JAS
JAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line4,8235,43313,55227,53221,224
Depreciation
Amortisation
Non-Cash Items1,286874722473-479
Unusual Items
Other Non-Cash Items
Changes in Working Capital-3,520-3,386-4,039-25,07411,502
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities5,7826,33813,9416,98536,896
Capital Expenditures-6,082-4,052-8,845-12,539-5,882
Purchase of Fixed Assets
Other Investing Cash Flow Items5063,8405,0675,468-811
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-5,576-212-3,778-7,071-6,693
Financing Cash Flow Items-1-1
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities-541-946-1,103-2,070-4,119
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-5874,9988,845-1,14826,897